Janus kinase inhibitors ruxolitinib and baricitinib impair glycoprotein-VI mediated platelet function

Iván Parra-Izquierdo, Alexander R. Melrose, Jiaqing Pang, Hari Hara Sudhan Lakshmanan, Stéphanie E. Reitsma, Sai Hitesh Vavilapalli, Mark K. Larson, Joseph J. Shatzel, Owen J.T. McCarty, Joseph E. Aslan

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'Janus kinase inhibitors ruxolitinib and baricitinib impair glycoprotein-VI mediated platelet function'. Together they form a unique fingerprint.

Medicine & Life Sciences